This section is password-protected. Please use the group password to access the documents.
Pazopanib improves progression-free survival without impairing health-related quality of life 06/07/2015
DATECAN initiative publishes Guidelines for time-to-event end point definitions in breast cancer trials 19/05/2015
EORTC opens trial for patients with high grade undifferentiated uterine sarcoma, a rare cancer 16/02/2015
Should first-line treatment for advanced or metastatic soft tissue sarcoma be doxorubicin alone or with ifosfamide? 25/03/2014
EORTC analysis characterizes long-term responders and survivors on pazopanib for advanced soft tissue sarcomas 10/02/2014
Moderate dose radiotherapy effective in EORTC trial for patients with desmoid-type fibromatosis... 18/07/2013
EORTC led intergroup trial investigates Imatinib failure-free survival in patients with localized GIST 29/05/2013